Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
Animals
Antibodies, Monoclonal
/ analysis
Antibodies, Neutralizing
/ analysis
Antibodies, Viral
/ analysis
Betacoronavirus
/ chemistry
COVID-19
Coronavirus Infections
/ immunology
Cryoelectron Microscopy
Disease Models, Animal
Epitope Mapping
Epitopes, B-Lymphocyte
/ chemistry
Female
Humans
Immunoglobulin Fab Fragments
/ chemistry
Lung
/ pathology
Male
Mesocricetus
Models, Molecular
Neutralization Tests
Pandemics
/ prevention & control
Pneumonia, Viral
/ immunology
SARS-CoV-2
Spike Glycoprotein, Coronavirus
/ chemistry
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
15
06
2020
accepted:
15
07
2020
pubmed:
23
7
2020
medline:
28
8
2020
entrez:
23
7
2020
Statut:
ppublish
Résumé
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic continues, with devasting consequences for human lives and the global economy
Identifiants
pubmed: 32698192
doi: 10.1038/s41586-020-2571-7
pii: 10.1038/s41586-020-2571-7
doi:
Substances chimiques
Antibodies, Monoclonal
0
Antibodies, Neutralizing
0
Antibodies, Viral
0
Epitopes, B-Lymphocyte
0
Immunoglobulin Fab Fragments
0
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
450-456Subventions
Organisme : NIGMS NIH HHS
ID : U24 GM129539
Pays : United States
Organisme : NIH HHS
ID : GM103310
Pays : United States
Commentaires et corrections
Type : UpdateOf
Références
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
doi: 10.1038/s41586-020-2012-7
Wang, C., Horby, P. W., Hayden, F. G. & Gao, G. F. A novel coronavirus outbreak of global health concern. Lancet 395, 470–473 (2020).
doi: 10.1016/S0140-6736(20)30185-9
Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292.e286 (2020).
doi: 10.1016/j.cell.2020.02.058
Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260–1263 (2020).
doi: 10.1126/science.abb2507
Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280.e278 (2020).
doi: 10.1016/j.cell.2020.02.052
Wang, Q. et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181, 894–904.e899 (2020).
doi: 10.1016/j.cell.2020.03.045
Ju, B. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature https://doi.org/10.1038/s41586-020-2380-z (2020).
Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290–295 (2020).
doi: 10.1038/s41586-020-2349-y
Cao, Y. et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells. Cell 182, 73–84.e16 (2020).
doi: 10.1016/j.cell.2020.05.025
Wu, Y. et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science 368, 1274–1278 (2020).
doi: 10.1126/science.abc2241
Hansen, J. et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science https://doi.org/10.1126/science.abd0827 (2020).
Sheng, Z. et al. Gene-specific substitution profiles describe the types and frequencies of amino acid changes during antibody somatic hypermutation. Front. Immunol. 8, 537 (2017).
doi: 10.3389/fimmu.2017.00537
ter Meulen, J. et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 3, e237 (2006).
doi: 10.1371/journal.pmed.0030237
Tian, X. et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg. Microbes Infect. 9, 382–385 (2020).
doi: 10.1080/22221751.2020.1729069
Yuan, M. et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science 368, 630–633 (2020).
doi: 10.1126/science.abb7269
Rogers, T. F. et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science https://doi.org/10.1126/science.abc7520 (2020).
Chen, X. et al. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor. Cell. Mol. Immunol. 17, 647–649 (2020).
doi: 10.1038/s41423-020-0426-7
Zeng, X. et al. Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy. Antib. Ther. 3, 95–100 (2020).
Liu, X. et al. Neutralizing antibodies isolated by a site-directed screening have potent protection on SARS-CoV-2 infection. Preprint at https://doi.org/10.1101/2020.05.03.074914 (2020).
Zost, S. J. et al. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Nat. Med. https://doi.org/10.1038/s41591-020-0998-x (2020).
doi: 10.1038/s41591-020-0998-x
pubmed: 32651581
Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 infection in convalescent individuals. Nature https://doi.org/10.1038/s41586-020-2456-9 (2020).
Brouwer, P. J. M. et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science https://doi.org/10.1126/science.abc5902 (2020).
Chi, X. et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science https://doi.org/10.1126/science.abc6952 (2020).
Wang, C. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat. Commun. 11, 2251 (2020).
doi: 10.1038/s41467-020-16256-y
Wang, P. et al. SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease. Preprint at https://doi.org/10.1101/2020.06.13.150250 (2020).
Schramm, C. A. et al. SONAR: a high-throughput pipeline for inferring antibody ontogenies from longitudinal sequencing of B cell transcripts. Front. Immunol. 7, 372 (2016).
doi: 10.3389/fimmu.2016.00372
Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389–3402 (1997).
doi: 10.1093/nar/25.17.3389
Lefranc, M. P. et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 37, D1006–D1012 (2009).
doi: 10.1093/nar/gkn838
Sievers, F. & Higgins, D. G. Clustal Omega, accurate alignment of very large numbers of sequences. Methods Mol. Biol. 1079, 105–116 (2014).
doi: 10.1007/978-1-62703-646-7_6
Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460–2461 (2010).
doi: 10.1093/bioinformatics/btq461
Nie, J. et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg. Microbes Infect. 9, 680–686 (2020).
doi: 10.1080/22221751.2020.1743767
Whitt, M. A. Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J. Virol. Methods 169, 365–374 (2010).
doi: 10.1016/j.jviromet.2010.08.006
Suloway, C. et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151, 41–60 (2005).
doi: 10.1016/j.jsb.2005.03.010
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
doi: 10.1038/nmeth.4169
Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153–1160 (2019).
doi: 10.1038/s41592-019-0575-8
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
doi: 10.1002/jcc.20084
Tan, Y. Z. et al. Addressing preferred specimen orientation in single-particle cryo-EM through tilting. Nat. Methods 14, 793–796 (2017).
doi: 10.1038/nmeth.4347
Zhu, K. et al. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction. Proteins 82, 1646–1655 (2014).
doi: 10.1002/prot.24551
Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D Struct. Biol. 74, 519–530 (2018).
doi: 10.1107/S2059798318002425
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
doi: 10.1107/S0907444904019158
Adams, P. D. et al. Recent developments in the PHENIX software for automated crystallographic structure determination. J. Synchrotron Radiat. 11, 53–55 (2004).
doi: 10.1107/S0909049503024130
Davis, I. W., Murray, L. W., Richardson, J. S. & Richardson, D. C. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res. 32, W615–W619 (2004).
doi: 10.1093/nar/gkh398
Barad, B. A. et al. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nat. Methods 12, 943–946 (2015).
doi: 10.1038/nmeth.3541
Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).
doi: 10.1002/pro.3235
Chan, J. F. et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa325 (2020).
Chan, J. F. et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay validated in vitro and with clinical specimens. J. Clin. Microbiol. 58, e00310-20 (2020).
doi: 10.1128/JCM.00310-20